Hutch News

Stories tagged 'precision medicine'

Bringing a leukemia treatment back to life with precision medicine

New research writes latest chapter in one drug's story

June 27, 2017 | by Susan Keown / Fred Hutch News Service

The leukemia drug gemtuzumab ozogamicin (Mylotarg) was pulled from the market seven years after initial approval. Now, new evidence may be bringing it back to life to treat a specific group of patients.

View story >


Aspirin and its cousins linked to longer survival after colorectal cancer

Large study of preventive drugs for colorectal cancer survivors finds link to decreased mortality — but only for those with certain tumor genetics

June 15, 2017 | By Rachel Tompa / Fred Hutch News Service

Aspirin and other NSAIDs are linked to decreased mortality in colorectal cancer survivors, a new study finds -- but just for those with the most common tumor subtype.

View story >


5 highlights from American Association for Cancer Research conference

Immunotherapy, health disparities, funding cuts among hot topics at annual meeting

April 7, 2017 | By Susan Keown / Fred Hutch News Service

Immunotherapy, health disparities and funding cuts were among hot topics at the annual meeting attended by more than 21,000 cancer researchers.

View story >


Finding ways to deliver on the promise of precision oncology

‘Functional genomics’ method aims to marry three powerful techniques to speed personalized cancer treatments to patients

March 31, 2017 | By Rachel Tompa / Fred Hutch News Service

Dr. Christopher Kemp is confident that the answer to personalized cancer treatment is written in the molecules inside each patient’s tumor, we just need to figure out how to separate the wheat from the chaff.

View story >


Looking back at the future

A roundup of some of our favorite 2016 stories on research at Fred Hutch

Dec. 30, 2016 | By Fred Hutch News Service staff

At Fred Hutch News Service, our writers witness daily the excitement of covering new developments in the science of cancer and the human immune system. As 2016 draws to a close, we asked them to sort through the stories about Fred Hutch research they had written this year, and offer our readers a selection of those they felt were most meaningful and important.

View story >


The quest to better understand the deadliest childhood leukemia

Oncologists are beginning to leverage unique genomic characteristics of pediatric AML to improve treatment and prognosis

Dec. 7, 2016 | By Sabrina Richards / Fred Hutch News Service

Acute myeloid leukemia is the deadliest leukemia among children. Only 60 percent of patients will achieve long-term remission. But scientists see change on the horizon.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.